Risankizumab
Records for this ingredient, by country (identity only).
ATC L04AC18 · 12 markets · 58 records
GB 7 records · 6 shown of 6
- 150 mg/1 mLinjectionSkyrizi 150mg/1ml solution for injection pre-filled pensSkyrizi 75mg/0.83ml solution for injection pre-filled syringes
- 600 mg/10 mLinjectionSkyrizi 600mg/10ml concentrate for solution for infusion vials
- 360 mg/2.4 mLinjectionSkyrizi 360mg/2.4ml solution for injection cartridges
- 180 mg/1.2 mLinjectionSkyrizi 360mg/2.4ml solution for injection cartridges
- 75 mg/0.83 mLinjectionSkyrizi 75mg/0.83ml solution for injection pre-filled syringes
- 55 mg/0.37 mLinjectionSkyrizi 75mg/0.83ml solution for injection pre-filled syringes
CA 7 records · 5 shown of 5
AU 7 records · 5 shown of 5
- 150 mg per mL / per unit basis not statedinjectionSKYRIZI risankizumab 150 mg/mL solution for injection pre-filled penSKYRIZI risankizumab 150 mg/mL solution for injection pre-filled syringe
- 150 mg/1 mLinjectionSkyrizi
- 600 mg per mL / per unit basis not statedinjectionSKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial
- 360 mg per mL / per unit basis not statedinjectionSKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system
- 180 mg per mL / per unit basis not statedinjectionSKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 6 records · 4 shown of 4
JP 6 records · 5 shown of 5
- 150 mg/1 mLinjectionスキリージ皮下注150mgシリンジ1mLスキリージ皮下注150mgペン1mL
- 600 mg/10 mLinjectionスキリージ点滴静注600mg
- 360 mg/2.4 mLinjectionスキリージ皮下注360mgオートドーザー
- 180 mg/1.2 mLinjectionスキリージ皮下注180mgオートドーザー
- 75 mg/0.83 mLinjectionスキリージ皮下注75mgシリンジ0.83mL
SG 5 records · 5 shown of 5
- 150 mg per mL / per unit basis not statedinjectionSKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/ML
- 600 mg/10 mLinjectionSKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML
- 360 mg/2.4 mLinjectionSKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED CARTRIDGE WITH ON-BODY INJECTOR 360MG/2.4ML
- 180 mg/1.2 mLinjectionSKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED CARTRIDGE WITH ON-BODY INJECTOR 360MG/2.4ML
- 150 mg/mL per mL / per unit basis not statedinjectionSKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML
ES 5 records · 4 shown of 4
- 150 mg per mL / per unit basis not statedinjectionSKYRIZI PRECARGADA
- 600 mg per mL / per unit basis not statedinjectionSkyrizi
- 360 mg per mL / per unit basis not statedinjectionSkyrizi
- 180 mg per mL / per unit basis not statedinjectionSkyrizi
HK 4 records · 0 shown of 0
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 4 records · 3 shown of 3
- 150 mg/1 mLinjectionSKYRIZI 150 mg, solution injectable en seringue préremplieSKYRIZI 150 mg, solution injectable en stylo prérempli
- 360 mg/2.4 mLinjectionSKYRIZI 360 mg, solution injectable en cartouche
- 600 mg per mL / per unit basis not statedinjectionSKYRIZI 600 mg, solution à diluer pour perfusion
TW 2 records · 2 shown of 2
- 150 mg per mL / per unit basis not statedinjectionSKYRIZI 150 mg/ml solution for喜開悅150 mg/ml注射劑
- 600 mg/10 mLinjectionSKYRIZI Concentrate for Solution for infusion 600mg/10ml Vial喜開悅靜脈注射劑600毫克/10毫升
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 150 mg per mL / per unit basis not stated cannot compare injection | Skyrizi | SKYRIZI risankizumab 150 mg/mL solution for injection pre-filled pen SKYRIZI risankizumab 150 mg/mL solution for injection pre-filled syringe | SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/ML | SKYRIZI PRECARGADA | SKYRIZI 150 mg/ml solution for 喜開悅150 mg/ml注射劑 | ||||||
| 150 mg/1 mL injection | Skyrizi 150mg/1ml solution for injection pre-filled pens Skyrizi 75mg/0.83ml solution for injection pre-filled syringes | Skyrizi | スキリージ皮下注150mgシリンジ1mL スキリージ皮下注150mgペン1mL | SKYRIZI 150 mg, solution injectable en seringue préremplie SKYRIZI 150 mg, solution injectable en stylo prérempli | |||||||
| 600 mg/10 mL injection | Skyrizi | Skyrizi 600mg/10ml concentrate for solution for infusion vials | SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML | SKYRIZI Concentrate for Solution for infusion 600mg/10ml Vial 喜開悅靜脈注射劑600毫克/10毫升 | スキリージ点滴静注600mg | ||||||
| 360 mg/2.4 mL injection | Skyrizi 360mg/2.4ml solution for injection cartridges | SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED CARTRIDGE WITH ON-BODY INJECTOR 360MG/2.4ML | スキリージ皮下注360mgオートドーザー | SKYRIZI 360 mg, solution injectable en cartouche | |||||||
| 180 mg/1.2 mL injection | Skyrizi | Skyrizi 360mg/2.4ml solution for injection cartridges | SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED CARTRIDGE WITH ON-BODY INJECTOR 360MG/2.4ML | スキリージ皮下注180mgオートドーザー | |||||||
| 600 mg per mL / per unit basis not stated cannot compare injection | SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial | Skyrizi | SKYRIZI 600 mg, solution à diluer pour perfusion | ||||||||
| 360 mg per mL / per unit basis not stated cannot compare injection | SKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system | Skyrizi | |||||||||
| 180 mg per mL / per unit basis not stated cannot compare injection | SKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system | Skyrizi | |||||||||
| 75 mg/0.83 mL injection | Skyrizi 75mg/0.83ml solution for injection pre-filled syringes | スキリージ皮下注75mgシリンジ0.83mL | |||||||||
| 55 mg/0.37 mL injection | Skyrizi | Skyrizi 75mg/0.83ml solution for injection pre-filled syringes | |||||||||
| 150 mg per mL / per unit basis not stated cannot compare liquid | Skyrizi | ||||||||||
| 150 mg/1 mL liquid | Skyrizi | ||||||||||
| 90 mg per mL / per unit basis not stated cannot compare liquid | Skyrizi | ||||||||||
| 60 mg per mL / per unit basis not stated cannot compare liquid | Skyrizi | ||||||||||
| 55 mg per mL / per unit basis not stated cannot compare liquid | Skyrizi | ||||||||||
| 150 mg/mL per mL / per unit basis not stated cannot compare injection | SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML | ||||||||||
unknown | Skyrizi | SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML SKYRIZI SOLUTION FOR INJECTION IN CARTRIDGE 360MG/2.4ML SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1ML+1SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/1ML | Skyrizi |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
6 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 6 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 6 个规格/剂型仅在 CA · SG 有记录（未在本表显示）。 另有 6 個規格/劑型僅在 CA · SG 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.